NSC |
Compound |
Enrichment |
Correlation |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0478540623811426 |
0.26588311 |
NSC 134459 |
Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) |
0.0478540623811426 |
0.03724618 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0478540623811426 |
-0.059652861 |
NSC 31780 |
3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) |
0.0478540623811426 |
-0.20418581 |
NSC 326061 |
1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide |
0.0478540623811426 |
-0.16217105 |
NSC 330507 |
Tanespimycin |
0.0478540623811426 |
0.097548024 |
NSC 359415 |
Null |
0.0478540623811426 |
0.083518944 |
NSC 38530 |
Null |
0.0478540623811426 |
-0.037438013 |
NSC 48526 |
Null |
0.0478540623811426 |
0.083779107 |
NSC 48890 |
Null |
0.0478540623811426 |
0.43570349 |